![]() |
市场调查报告书
商品编码
1567779
北美水生兽医市场预测至 2030 年 - 区域分析 - 按类型、诊断、治疗、物种、疾病来源和给药途径North America Aquatic Veterinary Market Forecast to 2030 - Regional Analysis - by Type, Diagnostic, Treatment, Species, Diseases Source, and Route of Administration |
2022年北美水生兽医市场估值为5.5703亿美元,预计到2030年将达到7.5198亿美元;预计2022年至2030年复合年增长率为3.8%。
政府发展水产养殖业的措施推动北美水产兽医市场
对海鲜的高需求和野生鱼类年捕捞量的下降是推动水产养殖业呈指数级增长的关键因素。因此,各国政府正采取措施改善和支持水产养殖业的发展。以下是最近的一些倡议:
2021年2月,食品与农业研究基金会(FFAR)筹集了790,326美元资金,用于创建疫苗输送系统,以防止罗非鱼湖病毒感染和其他疾病在水产养殖领域的传播。
Sea Grant 海洋水产养殖资助计划:这项全国性的竞争性资助计划,正式名称为“国家海洋水产养殖计划 (NMAI)”,旨在促进研究和示范计划,以推动美国可持续海水养殖。
2022 年,美国农业部国家食品和农业研究所 (NIFA) 宣布投资超过 1,300 万美元,用于研究动物疾病的新疗法和预防措施,这些疾病给全球农业部门带来了数十亿美元的损失。其中包括向密西西比州立大学拨款 625,000 美元,用于评估一种抗菌饲料添加剂,该添加剂可用于以安全有效的方式预防鲶鱼肠败血症。这项研究将有助于开发水产养殖生产者的处理替代方案,并提高生产效率。因此,政府支持水产养殖业发展的倡议的增加推动了水产兽医市场的成长。
北美水产兽医市场概况
据美国国家海洋和大气管理局称,美国水产养殖每年创收约 15 亿美元。世界银行表示,美国透过水产养殖生产了约 44.8 万吨产品。据同一来源称,2021年北美水产养殖业生产了约560万条鱼类,其中美国产量约470万条,即占该地区鱼类总产量的约83%。根据《2020 年美国渔业报告》,2020 年美国商业渔民捕获了84 亿英镑,价值47 亿美元。鱼鱼并释放了捕获的 65%。整体休閒收穫量估计为 3.44 亿条鱼,重达 3.53 亿磅。因此,蓬勃发展的水产养殖业推动了美国北美水产兽医市场的成长。
2020年9月,维克集团从专门从事研发生物学的动物保健公司Ictyogroup收购了多种罗非鱼疫苗。该集团获得了在全球范围内分销和营销这些註册自体疫苗的权利。两家公司建立了合作伙伴关係,为 Aqua Virbac 部门开发新配方和新疫苗。该协议还允许将几名专门从事技术行销支援和研发生物学的员工从 Ictyogroup 转移到维克。
2020 年 7 月,硕腾从 Benchmark Holdings, PLC 收购了 Fish Vet Group,对其製药业务进行了策略补充。 Zoetis 的製药业务负责商业化和开发鱼类疫苗,并为水产养殖提供疫苗接种和诊断服务。收购 Fish Vet Group 帮助 Zoetis 增强了其诊断专业知识和测试服务,包括 Pharmaq 参考实验室的环境测试。因此,美国水产养殖业各个市场参与者的策略性倡议支撑了美国的北美水生兽医市场。
北美水产兽医市场收入及 2030 年预测(百万美元)
北美水产兽医市场细分
北美水生兽医市场按类型、物种、疾病来源、其他给药途径和国家分类。
根据类型,北美水生兽医市场分为诊断和治疗。到 2022 年,治疗细分市场将占据更大的市场份额。治疗部分进一步细分为疫苗、药物和补充剂。
依物种划分,北美水生兽医市场分为鱼类、甲壳类、软体动物等。 2022 年,鱼类市场占据最大的市场份额。
根据疾病来源,北美水生兽医市场分为细菌、病毒、寄生虫等。 2022 年,细菌细分市场占据最大的市场。
从给药途径来看,北美水产兽医市场分为水用药、药饲料和其他给药途径。 2022 年,水药物领域占据最大的市场份额。
依国家划分,北美水生兽医市场分为美国、加拿大和墨西哥。 2022年,美国在北美水生兽医市场占有率中占据主导地位。
Aquatic Diagnostics Ltd、Ceva Polchem Pvt Ltd、Elanco Animal Health Inc、HIPRA SA、Merck KGaA、Phibro Animal Health Corp、Thermo Fisher Scientific Inc、Virbac SA 和 Zoetis Inc 是北美水产兽医市场上的一些领先公司。
The North America aquatic veterinary market was valued at US$ 557.03 million in 2022 and is expected to reach US$ 751.98 million by 2030; it is estimated to register a CAGR of 3.8% from 2022 to 2030.
Government Initiatives to Develop Aquaculture Industry Fuel North America Aquatic Veterinary Market
The high demand for seafood and the decreasing annual catch of wild fish are crucial factors that can drive the growth of the aquaculture industry at an exponential rate. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:
In February 2021, the Foundation for Food & Agriculture Research (FFAR) raised funds of US$ 790,326 to create a vaccine delivery system to prevent the spread of tilapia lake virus infections and other diseases in the aquaculture sector.
Sea Grant Marine Aquaculture Grant Program: This nationwide competitive grant program, officially known as the "National Marine Aquaculture Initiative (NMAI)," promotes research and demonstration initiatives to advance sustainable marine aquaculture in the US.
In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency. Thus, an increase in government initiatives to support developments in the aquaculture industry drives the aquatic veterinary market growth.
North America Aquatic Veterinary Market Overview
According to the National Oceanic and Atmospheric Administration, aquaculture generates ~US$ 1.5 billion annually in the US. The World Bank states that the US produced ~448 thousand metric ton of products out of aquaculture. As per the same source, ~5.6 million fishes were produced by the North American aquaculture industry in 2021, of which the US accounted for the production of ~4.7 million, i.e., ~83% of the total regional fish production. According to the Fisheries of the US 2020 report, commercial fishermen in the US landed 8.4 billion pounds valued at US$ 4.7 billion in 2020. Anglers in the country took nearly 200 million trips for recreational fisheries in 2020. These recreational anglers caught approximately 1 billion fish and released 65% of those caught. The overall recreational harvest was estimated at 344 million fish weighing 353 million pounds. Thus, the flourishing aquaculture industry fuels the growth of the North America aquatic veterinary market in the US.
In September 2020, the Virbac Group acquired various tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology. The group received rights for the distribution and marketing of these registered, autogenous vaccines worldwide. The two companies had a partnership for the development of new formulations and new vaccines for the Aqua Virbac division. The agreement also allowed the transfer of several employees specialized in technical marketing support and R&D biology from Ictyogroup to Virbac.
In July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC to make a strategic addition to its pharma business. The pharmaceutical business of Zoetis commercializes and develops fish vaccines and offers vaccination and diagnostic services for aquaculture. The acquisition of Fish Vet Group helped Zoetis enhance its diagnostics expertise and testing services, including environmental testing, that Pharmaq's reference lab. Thus, strategic initiatives by various market players in the US aquaculture industry bolster the North America aquatic veterinary market in the US.
North America Aquatic Veterinary Market Revenue and Forecast to 2030 (US$ Million)
North America Aquatic Veterinary Market Segmentation
The North America aquatic veterinary market is categorized into type, species, diseases source, other route of administration, and country.
Based on type, the North America aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held a larger market share in 2022. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.
By species, the North America aquatic veterinary market is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest market share in 2022.
Based on diseases source, the North America aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest market share in 2022.
In terms of route of administration, the North America aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest market share in 2022.
By country, the North America aquatic veterinary market is segmented into the US, Canada, and Mexico. The US dominated the North America aquatic veterinary market share in 2022.
Aquatic Diagnostics Ltd, Ceva Polchem Pvt Ltd, Elanco Animal Health Inc, HIPRA SA, Merck KGaA, Phibro Animal Health Corp, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the North America aquatic veterinary market.